Sara Carloni

Sara Carloni

Auto-generated profile, based on publicly available information

Sara Carloni

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2020 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
EZElena Zagato
Elena Zagato
CPChiara Pozzi
Chiara Pozzi
ABAlice Bertocchi
Alice Bertocchi
TSTiziana Schioppa
Tiziana Schioppa
FSFabiana Saccheri
Fabiana Saccheri
MRMaria Rescigno
Maria Rescigno

5 December 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
CBClaudia Burrello
Claudia Burrello
FGFederica Garavaglia
Federica Garavaglia
FCFulvia Milena Cribiù
Fulvia Milena Cribiù
GEGiulia Ercoli
Giulia Ercoli
GLGianluca Lopez
Gianluca Lopez
FFFederica Facciotti
Federica Facciotti
Alteration of the gut microbiota has been associated with different gastrointestinal disorders. Normobiosis restoration by faecal microbiota transplantation (FMT) is considered a promising therapeutic approach, even if the mechanisms underlying its efficacy are at present largely unknown. Here we sought to elucidate the functional effects of therapeutic FMT administration during experimental colitis on innate and adaptive immune responses in the intestinal mucosa. We show that therapeutic FMT reduces colonic inflammation and initiates the restoration of intestinal homeostasis through the simultaneous activation of different immune-mediated pathways, ultimately leading to IL-10 production by innate and adaptive immune cells, including CD4+ T cells, iNKT cells and Antigen Presenting Cells (APC), and reduces the ability of dendritic cells, monocytes and macrophages to present MHCII-dependent bacterial antigens to colonic T cells. These results demonstrate the capability of FMT to therapeutically control intestinal experimental colitis and poses FMT as a valuable therapeutic option in immune-related pathologies.

22 October 2021 in Science
Verified
Journal Article
Closed access
SCSara Carloni
Sara Carloni
ABAlice Bertocchi
Alice Bertocchi
SMSara Mancinelli
Sara Mancinelli
MBMartina Bellini
Martina Bellini
MEMarco Erreni
Marco Erreni
MRMaria Rescigno
Maria Rescigno
Locking down access to the brain: Inflammatory bowel disease is best known for intestinal symptoms but can also cause a variety of extraintestinal manifestations in other organs. It can also be associated with cognitive and psychiatric effects, including anxiety and depression. Using mouse models of intestinal inflammation, Carloni et al . uncovered a potential pathogenic link between these aspects of inflammatory bowel disease. The inflammatory process causes the gut vascular barrier to become more permeable, resulting in the spread of inflammation beyond the intestine, while the vascular barrier in the choroid plexus shuts down, helping protect the brain from inflammation but also potentially impairing communication between organs and impairing some brain functions. —YN

3 September 2014 in Environmental Microbiology
Verified
Journal Article
Closed access
PDF file
SFSilvia Ferrara
Silvia Ferrara
SCSara Carloni
Sara Carloni
RFRoberta Fulco
Roberta Fulco
MFMarilena Falcone
Marilena Falcone
RMRaffaella Macchi
Raffaella Macchi
GBGiovanni Bertoni
Giovanni Bertoni

9 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
SGSilvia Giugliano
Silvia Giugliano
AGAndrea Gatti
Andrea Gatti
MRMartina Rusin
Martina Rusin
TSTilo Schorn
Tilo Schorn
SPSilvia Pimazzoni
Silvia Pimazzoni
MRMaria Rescigno
Maria Rescigno
Preeclampsia is a leading cause of morbidity and mortality in pregnant women, affecting 5–8% of gestations worldwide. Its development is influenced by maternal immune abnormalities, metabolic disorders, and gut dysbiosis. In this study, we show that gut dysbiosis in pregnant C57BL/6J dams leads to increased fetal resorption, impaired placental development and altered vascularization. These adverse outcomes are associated with key pathological features of preeclampsia, including hypoxia, endoplasmic reticulum (ER) stress and reduction in uterine natural killer (NK) cell numbers. Furthermore, gut dysbiosis significantly perturbs placental carbohydrate metabolism, which impairs NK cell IFN-γ secretion. Notably, glucose supplementation restores placental NK cell function and reduces fetal resorption, suggesting that the observed impairment is reversible and dependent on a lower glycolytic rate. These findings highlight maternal gut microbiota as a key player in carbohydrate metabolism, with a pivotal role in modulating placental immunity and pregnancy outcome. The results provide valuable insights into potential metabolic biomarkers and suggest that targeting the gut microbiota may offer a strategy for preventing preeclampsia.

15 September 2017 in Environmental Microbiology
Verified
Journal Article
Closed access
PDF file
SCSara Carloni
Sara Carloni
RMRaffaella Macchi
Raffaella Macchi
SSSara Sattin
Sara Sattin
SFSilvia Ferrara
Silvia Ferrara
GBGiovanni Bertoni
Giovanni Bertoni